Healthcare Industry News: Novation
News Release - April 13, 2015
RTI Surgical(R) Announces Agreement with Novation, One of the Nation’s Leading Healthcare Services CompaniesALACHUA, Fla.--(Healthcare Sales & Marketing Network)--RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a leading global surgical implant company, announced a new agreement with Novation, a health care services company with more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista, LLC. The agreement covers RTI’s full line of surgical specialties implants and is effective starting April 1, 2015.
RTI Surgical is the only provider offering a complete line of biologic implants for hernia repair, complex abdominal wall repair cases and breast reconstruction surgeries, providing surgeons multiple tissue types to better meet the patient’s clinical needs. The portfolio includes Fortiva™ porcine dermis, Tutopatch™ bovine pericardium, Tutomesh™ fenestrated bovine pericardium and Cortiva™ allograft dermis.
These implants are sterilized through the patented Tutoplast® Tissue Sterilization Process, a validated chemical sterilization process that thoroughly penetrates tissue, removing antigenicity and inactivating pathogens. Terminal sterilization using low dose gamma irradiation achieves a sterility assurance level (SAL) of 10-6.
“We are very excited to announce this agreement with Novation,” said Brian K. Hutchison, president and CEO of RTI Surgical. “We look forward to offering the members served by Novation our complete portfolio of biologic implants for hernia repair and breast reconstruction, backed by our track record of more than five million sterilized implants distributed with zero incidence of implant-associated infection.”
For more information about RTI’s comprehensive line of biologic implants used for hernia repair and breast reconstruction, please visit www.rtisurgical.com or contact an RTI representative at (877) 612-4287.
About RTI Surgical Inc.
RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.
Novation is the nation’s leading health care services company, focused on revolutionizing operational performance for more than 100,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista LLC. Novation’s progressive approach to cost performance, data and intelligence, and integrated advisory solutions helps health care providers envision and advance new models of cost-effective, high-quality care. Headquartered in Irving, Texas, Novation is committed to the highest standards of ethical behavior and twice has been honored with the Ethisphere Institute’s coveted Ethics Inside® Certification, and has been named four years consecutively to Ethisphere’s World’s Most Ethical Companies list.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about anticipated financial results, growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting RTI's website at www.rtix.com or the SEC's website at www.sec.gov.
Source: RTI Surgical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.